These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 24019897)

  • 1. Distinct internalization pathways of human amylin monomers and its cytotoxic oligomers in pancreatic cells.
    Trikha S; Jeremic AM
    PLoS One; 2013; 8(9):e73080. PubMed ID: 24019897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clustering and internalization of toxic amylin oligomers in pancreatic cells require plasma membrane cholesterol.
    Trikha S; Jeremic AM
    J Biol Chem; 2011 Oct; 286(41):36086-36097. PubMed ID: 21865171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasome regulates turnover of toxic human amylin in pancreatic cells.
    Singh S; Trikha S; Sarkar A; Jeremic AM
    Biochem J; 2016 Sep; 473(17):2655-70. PubMed ID: 27340132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copper(II)-human amylin complex protects pancreatic cells from amylin toxicity.
    Lee EC; Ha E; Singh S; Legesse L; Ahmad S; Karnaukhova E; Donaldson RP; Jeremic AM
    Phys Chem Chem Phys; 2013 Aug; 15(30):12558-71. PubMed ID: 23793354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human serum protein C4b-binding protein inhibits pancreatic IAPP-induced inflammasome activation.
    Kulak K; Westermark GT; Papac-Milicevic N; Renström E; Blom AM; King BC
    Diabetologia; 2017 Aug; 60(8):1522-1533. PubMed ID: 28500395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Baboon IAPP Provides Insight into Amyloidogenicity and Cytotoxicity of Human IAPP.
    Ridgway Z; Lee KH; Zhyvoloup A; Wong A; Eldrid C; Hannaberry E; Thalassinos K; Abedini A; Raleigh DP
    Biophys J; 2020 Mar; 118(5):1142-1151. PubMed ID: 32105649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The processing intermediate of human amylin, pro-amylin(1-48), has in vivo and in vitro bioactivity.
    Mazzini G; Le Foll C; Boyle CN; Garelja ML; Zhyvoloup A; Miller MET; Hay DL; Raleigh DP; Lutz TA
    Biophys Chem; 2024 May; 308():107201. PubMed ID: 38452520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.
    Westermark P; Andersson A; Westermark GT
    Physiol Rev; 2011 Jul; 91(3):795-826. PubMed ID: 21742788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Amylin: From Pathology to Physiology and Pharmacology.
    Ling W; Huang YM; Qiao YC; Zhang XX; Zhao HL
    Curr Protein Pept Sci; 2019; 20(9):944-957. PubMed ID: 30919775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus.
    Jeong HR; An SS
    Clin Interv Aging; 2015; 10():1873-9. PubMed ID: 26604727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential antagonism of amylin's metabolic and vascular actions with amylin receptor antagonists.
    Beaumont K; Moore CX; Pittner RA; Prickett KS; Gaeta LS; Rink TJ; Young AA
    Can J Physiol Pharmacol; 1995 Jul; 73(7):1025-9. PubMed ID: 8846395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Human Amylin Aggregation and Cellular Toxicity by Lipoic Acid and Ascorbic Acid.
    Azzam SK; Jang H; Choi MC; Alsafar H; Lukman S; Lee S
    Mol Pharm; 2018 Jun; 15(6):2098-2106. PubMed ID: 29709194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oleuropein aglycon prevents cytotoxic amyloid aggregation of human amylin.
    Rigacci S; Guidotti V; Bucciantini M; Parri M; Nediani C; Cerbai E; Stefani M; Berti A
    J Nutr Biochem; 2010 Aug; 21(8):726-35. PubMed ID: 19616928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Cholesterol and Phospholipids in Amylin Misfolding, Aggregation and Etiology of Islet Amyloidosis.
    Singh S; Trikha S; Bhowmick DC; Sarkar AA; Jeremic AM
    Adv Exp Med Biol; 2015; 855():95-116. PubMed ID: 26149927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition.
    Adler BL; Yarchoan M; Hwang HM; Louneva N; Blair JA; Palm R; Smith MA; Lee HG; Arnold SE; Casadesus G
    Neurobiol Aging; 2014 Apr; 35(4):793-801. PubMed ID: 24239383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraneuronal Amylin Deposition, Peroxidative Membrane Injury and Increased IL-1β Synthesis in Brains of Alzheimer's Disease Patients with Type-2 Diabetes and in Diabetic HIP Rats.
    Verma N; Ly H; Liu M; Chen J; Zhu H; Chow M; Hersh LB; Despa F
    J Alzheimers Dis; 2016 May; 53(1):259-72. PubMed ID: 27163815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzbromarone, Quercetin, and Folic Acid Inhibit Amylin Aggregation.
    López LC; Varea O; Navarro S; Carrodeguas JA; Sanchez de Groot N; Ventura S; Sancho J
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures.
    Bennett RG; Hamel FG; Duckworth WC
    Diabetes; 2003 Sep; 52(9):2315-20. PubMed ID: 12941771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis signal regulating kinase-1 and NADPH oxidase mediate human amylin evoked redox stress and apoptosis in pancreatic beta-cells.
    Singh S; Bhowmick DC; Pany S; Joe M; Zaghlula N; Jeremic AM
    Biochim Biophys Acta Biomembr; 2018 Sep; 1860(9):1721-1733. PubMed ID: 29627323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional proteasome complex is required for turnover of islet amyloid polypeptide in pancreatic β-cells.
    Chatterjee Bhowmick D; Jeremic A
    J Biol Chem; 2018 Sep; 293(37):14210-14223. PubMed ID: 30012886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.